A heritable predisposition to pituitary tumors

Pituitary

Volumn 13, Issue 2, 2010, Pages 130-137

  Couldwell, William T ^a   Cannon Albright, Lisa ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Medical Center   (United States)

Author keywords

Genetic predisposition; Pituitary tumor; UPDB

Indexed keywords

ARTICLE; BENIGN TUMOR; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENEALOGY; GENETIC DISTANCE; GENETIC PREDISPOSITION; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; FACTUAL DATABASE; GENETICS; PEDIGREE; RISK FACTOR;

DATABASES, FACTUAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEDIGREE; PITUITARY NEOPLASMS; RISK FACTORS;

EID: 77955880908     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-009-0212-0     Document Type: Article

References (56)

1. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197:18-24
2. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005) Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 117:655-661
3. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K (2006) Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27: 708-712
4. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK (1993) Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132:459-467
5. Arzt E, Pereda MP, Castro CP, Pagotto U, Renner U, Stalla GK (1999) Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 20:71-95
6. Arzt E (2001) gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 108:1729-1733
7. Arzt E, Chesnokova V, Stalla GK, Melmed S (2009) Pituitary adenoma growth: a model for cellular senescence and cytokine action. Cell Cycle 8:677-678
8. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A (2007) Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92:1952-1955
9. Bishop DT, Skolnick MH (1984) Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers. J Cell Physiol Suppl 3:63-77
10. Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH (1985) Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312:1540-1544
11. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994) Familiality of cancer in Utah. Cancer Res 54:2378-2385
12. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003) A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 99:637-643
13. Cannon LA, Bishop DT, Skolnick M, Hunt SC, Lyon JL, Smart C (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:48-69
14. CBTRUS (2002) Statistical report: primary brain tumors in the United States, 1995-1999. Central Brain Tumor Registry of the United States, Hinsdale
15. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K, Melmed S (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67:10564-10572
16. Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S, Melmed S (2008) p21(Cip1) restrains pituitary tumor growth. Proc Natl Acad Sci USA 105:17498-17503
17. Couldwell WT (2004) Transsphenoidal and transcranial surgery for pituitary adenomas. J Neurooncol 69:237-256
18. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316-3323
19. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896
20. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3:152-158
21. Dudley KJ, Revill K, Clayton RN, Farrell WE (2009) Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42:461-468
22. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613-619
23. Farrell WE (2005) Epigenetic mechanisms of tumorigenesis. Horm Metab Res 37:361-368
24. Fernandez A, Karavitaki N, Wass JA (2009) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 24 July 2009 [Epub ahead of print]
25. Giacomini D, Paez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, Gerez J, Chervin A, Berner S, Losa M, Buchfelder M, Renner U, Stalla GK, Arzt E (2006) Bone morphogenetic protein- 4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147:247-256
26. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608
27. Gulcher J, Stefansson K (1998) Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36:523-527
28. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317-1321
29. Hill J (1980) A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor
30. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004) Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 110:3143-3148
31. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006) Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 152:305-311
32. Jacoby LB, Hedley-Whyte ET, Pulaski K, Seizinger BR, Martuza RL (1990) Clonal origin of pituitary adenomas. J Neurosurg 73:731-735
33. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:245-254
34. Jonsson H, Manolescu I, Stefansson SE, Ingvarsson T, Jonsson HH, Manolescu A, Gulcher J, Stefansson K (2003) The inheritance of hand osteoarthritis in Iceland. Arthritis Rheum 48: 391-395
35. Jorde LB (1989) Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 53:339-355
36. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene- induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019-1031
37. Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239:637-645 Discussion 645-1637
38. Malécot G (1948) Les mathématiques de l'héré dité. Masson, Paris
39. Maul JS, Burt RW, Cannon-Albright LA (2007) A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 5:1080-1084
40. McLellan T, Jorde LB, Skolnick MH (1984) Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 36:836-857
41. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85:1420-1425
42. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 100:1034-1039
43. Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441
44. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:735-740
45. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602
46. Skolnick M (1980) The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M (eds) Banbury Report No 4 Cancer incidence in defined populations. Cold Spring Harbor Laboratory, Cold Spring Harbor
47. Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 343:1765-1770
48. Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon- Albright L (2009) Evidence for an inherited predisposition contributing to risk for rotator disease. J Bone Joint Surg 91:1136-1142
49. Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007) A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 176:865-870
50. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999) Familial associations between cancer sites. Comput Biomed Res 32:517-529
51. Tichomirowa MA, Daly AF, Beckers A (2009) Familial pituitary adenomas. J Intern Med 266:5-18
52. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704
53. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230
54. Woloschak M, Yu A, Post KD (1997) Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog 19:221-224
55. Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS (2008) Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22: 380-387
56. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-767